First drug developed in Buffalo begins human trials
By CARLY CLEMONS | Dec. 3, 2007David Hangauer, associate professor of chemistry at UB and senior vice president of Kinex Pharmaceuticals, developed a new anti-cancer drug after 15 years of research at UB, which has recently begun its first phase of human testing.









